HighTower Advisors, LLC - TONIX PHARMACEUTICALS HLDG C ownership

TONIX PHARMACEUTICALS HLDG C's ticker is and the CUSIP is 890260706. A total of 41 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
HighTower Advisors, LLC ownership history of TONIX PHARMACEUTICALS HLDG C
ValueSharesWeighting
Q2 2021$23,000
-30.3%
21,336
-19.0%
0.00%
Q1 2021$33,000
+3.1%
26,335
-44.4%
0.00%
Q4 2020$32,000
+39.1%
47,335
+73.2%
0.00%
Q3 2020$23,000
+4.5%
27,335
-22.6%
0.00%
Q2 2020$22,000
+46.7%
35,335
+65.6%
0.00%
Q1 2020$15,00021,3350.00%
Other shareholders
TONIX PHARMACEUTICALS HLDG C shareholders Q4 2020
NameSharesValueWeighting ↓
GSA CAPITAL PARTNERS LLP 432,503$554,0000.09%
MONECO Advisors, LLC 35,000$45,0000.02%
Purus Wealth Management, LLC 15,000$19,0000.02%
Renaissance Technologies 8,454,364$10,822,0000.01%
LMR Partners LLP 390,864$500,0000.01%
ExodusPoint Capital Management, LP 595,459$762,0000.01%
LINCOLN CAPITAL CORP 12,000$15,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 264,500$339,0000.01%
HRT FINANCIAL LP 347,816$445,0000.01%
FIRST MIDWEST BANK TRUST DIVISION 25,000$32,0000.00%
View complete list of TONIX PHARMACEUTICALS HLDG C shareholders